Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients

Amerigo Boiardi, Antonio Silvani, Pier Adelchi Ruffini, Licia Rivoltini, Giorgio Parmiani, Giovanni Broggi, Andrea Salmaggi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients'. Together they form a unique fingerprint.

Medicine & Life Sciences